Overview

Chewed Versus Integral Pill of Ticagrelor

Status:
Active, not recruiting
Trial end date:
2021-07-31
Target enrollment:
Participant gender:
Summary
Hypothesis The primary question the investigators propose to answer is whether all patients undergoing PCI with stent deployment who receive chewed ticagrelor will demonstrate more rapid drug absorption and decreased platelet reactivity as compared to integral pill form 1 hour after drug administration.
Phase:
Phase 4
Details
Lead Sponsor:
Aurora Health Care
Treatments:
Ticagrelor